https://www.selleckchem.com/pr....oducts/namodenoson-c
nary-related discharges in a vulnerable end-stage renal disease population. In the first week following discharge, greater PM -related risk of rehospitalisation was identified for some diagnoses. Daily ambient PM2.5 was associated with an increased risk of cardiovascular admissions and 30-day readmissions following cardiopulmonary-related discharges in a vulnerable end-stage renal disease population. In the first week following discharge, greater PM2.5-related risk of rehospitalisation was identified for some diagnoses. Mater